Medivir has appointed Malene Jensen as Vice President Clinical Development.
She will assume her role as VP Clinical Development at the latest October 1, 2021. Jensen will also join the company’s executive team.
Malene Jensen has held various leadership positions within Clinical Development in the pharmaceutical industry for the past 15 years, including at AstraZeneca, Affibody and most recently as Director Global Clinical Development at Sedana Medical. She holds a PhD in Clinical Neuroscience from Karolinska Institutet in Stockholm.
“We are pleased to welcome Malene and her vast clinical development experience to Medivir. Malene will focus on the clinical trials with our key program, MIV-818, and she will be a valuable member of the management team,” says Magnus Christensen, Interim CEO of Medivir.